BRAF V600 MUTATED MELANOMA
Clinical trials for BRAF V600 MUTATED MELANOMA explained in plain language.
Never miss a new study
Get alerted when new BRAF V600 MUTATED MELANOMA trials appear
Sign up with your email to follow new studies for BRAF V600 MUTATED MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Study to zap resistant melanoma spots with surgery or radiation pulled before start
Disease control TerminatedThis study planned to test whether adding surgery, radiation, or electrochemotherapy could help control melanoma tumors that did not shrink with encorafenib + binimetinib combination therapy. It was designed for adults with BRAF-mutated melanoma who had been on the drugs for at l…
Matched conditions: BRAF V600 MUTATED MELANOMA
Phase: PHASE4 • Sponsor: SRH Wald-Klinikum Gera GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Triple-Drug cocktail targets tough melanoma
Disease control OngoingThis early-phase trial tests a new three-drug combination for people with advanced BRAF-mutated melanoma that cannot be removed by surgery. The drugs are XL888 (an HSP90 inhibitor), vemurafenib, and cobimetinib. The main goal is to find the safest dose of XL888 when given with th…
Matched conditions: BRAF V600 MUTATED MELANOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC